{"altmetric_id":1937192,"counts":{"readers":{"mendeley":18,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["_carcinoid_news"],"posts_count":1}},"citation":{"abstract":"Surgery in carcinoid patients can provoke a carcinoid crisis, which can have serious sequelae, including death. Octreotide prophylaxis is recommended to prevent carcinoid crisis, however there are few reports of outcomes and no large series examining its efficacy. We hypothesized that a 500 \u00b5g prophylactic octreotide dose is sufficient to prevent carcinoid crisis.","abstract_source":"pubmed","altmetric_jid":"4f6fa62a3cf058f610007e75","authors":["Kristen Massimino","Ola Harrskog","Suellen Pommier","Rodney Pommier"],"doi":"10.1002\/jso.23323","first_seen_on":"2013-11-27T06:00:27+00:00","issns":["1096-9098"],"issue":"8","journal":"Journal of Surgical Oncology","last_mentioned_on":1385531864,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23592524"],"pmid":"23592524","pubdate":"2013-06-01T00:00:00+00:00","scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms","generalsurgery"],"title":"Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.","type":"article","volume":"107","mendeley_url":"http:\/\/www.mendeley.com\/research\/octreotide-lar-bolus-octreotide-insufficient-preventing-intraoperative-complications-carcinoid-patie"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4507509,"mean":5.1386389830674,"rank":3065349,"this_scored_higher_than_pct":20,"this_scored_higher_than":943921,"rank_type":"exact","sample_size":4507509,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":120061,"mean":7.1297945027489,"rank":78537,"this_scored_higher_than_pct":22,"this_scored_higher_than":26846,"rank_type":"exact","sample_size":120061,"percentile":22},"this_journal":{"total_number_of_other_articles":612,"mean":1.2738036006547,"rank":324,"this_scored_higher_than_pct":33,"this_scored_higher_than":208,"rank_type":"exact","sample_size":612,"percentile":33},"similar_age_this_journal_3m":{"total_number_of_other_articles":18,"mean":1.344,"rank":8,"this_scored_higher_than_pct":44,"this_scored_higher_than":8,"rank_type":"exact","sample_size":18,"percentile":44}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":4,"Student  > Doctoral Student":2,"Researcher":3,"Student  > Ph. D. Student":4,"Student  > Postgraduate":1,"Other":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":13,"Neuroscience":1,"Agricultural and Biological Sciences":2,"Unspecified":2}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/_carcinoid_news\/status\/405576150966996992","license":"public","citation_ids":[1937192],"posted_on":"2013-11-27T05:57:44+00:00","author":{"name":"_carcinoid_news","image":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_0_normal.png","id_on_source":"_carcinoid_news","tweeter_id":"2209654909","followers":6},"tweet_id":"405576150966996992"}]}}